Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)
NCT ID: NCT02195323
Last Updated: 2016-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
7 participants
INTERVENTIONAL
2014-04-30
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease
NCT05362786
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
NCT06752577
Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells
NCT03321942
Stem Cell Therapy for Chronic Kidney Disease
NCT04869761
Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant.
NCT02563366
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MSC recipient
The patients with CKD who underwent intravenous injection of MSC.
Intravenous injection
Intravenous injection of bone marrow derived MSC in patients with CKD.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intravenous injection
Intravenous injection of bone marrow derived MSC in patients with CKD.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CKD symptoms
* CKD confirmed with serum and urine analysis and GFR 25-60 mL/min/1.73 m2
* Patient's age between 25 - 60 years
* Ability to understand and willingness to sign consent from
Exclusion Criteria
* Basis disease such as diabetes, malignancy and autoimmune
* Unable to follow post-operative exercise regimen or return for evaluations
25 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Royan Institute
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hamid Gourabi, PhD
Role: STUDY_CHAIR
Head of Royan Institute
Nasser Aghdami, MD,PhD
Role: STUDY_DIRECTOR
Head of regenerative medicine department &cell therapy center of Royan Institute
Atieh Makhloogh, MD
Role: STUDY_DIRECTOR
Mazandaran University of Medical Sciences, Mazandaran, Iran
Reza Moghadasali, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Regenerative Medicine And Royan Cell Therapy Center Royan Institute For stem Cell Biology and Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royan Institute
Tehran, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Royan-Kidney-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.